Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
November 01 2024 - 5:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
| | |
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ |
Check the appropriate box:
| | | | | |
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
☒ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to §240.14a-12 |
| | |
Salarius Pharmaceuticals, Inc. |
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| | | | | | | | |
☒ | No fee required. |
| | |
☐ | Fee paid previously with preliminary materials. |
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| (1) | Amount Previously Paid: |
| | |
| (2) | Form, Schedule or Registration Statement No.: |
| | |
| (3) | Filing Party: |
| | |
| (4) | Date Filed: |
| | |
Salarius Pharmaceuticals (NASDAQ:SLRX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Salarius Pharmaceuticals (NASDAQ:SLRX)
Historical Stock Chart
From Dec 2023 to Dec 2024